SCHEMBL4674480

SCHEMBL4674480

CCC(C1CC(n2nnc3ccccc32)CCN1C(=O)O)N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.44
▸ USP2 O75604 4/20 0.42
▸ CHRM4 P08173 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ GAA P10253 1/20 0.39
▸ MAPK1 P28482 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ CCR5 P51681 1/20 0.38
▸ TNKS O95271 1/20 0.38
▸ PARP1 P09874 1/20 0.38
▸ PARP2 Q9UGN5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4682261 0.84 DRD2 (0.44) ALDH1A1USP2KMT2AGAACCR5
SCHEMBL4674487 0.83 ALDH1A1 (0.45) ALDH1A1USP2CHRM4KDM4EMAPT
SCHEMBL4674486 0.83 ALDH1A1 (0.45) ALDH1A1USP2CHRM4KDM4EMAPT
SCHEMBL4678001 0.80 FPR2 (0.42) MAPTCYP2D6CYP2C19CCR5
SCHEMBL3803735 0.79 OPRM1 (0.49) ALDH1A1CHRM4KDM4ECYP2D6NPSR1
SCHEMBL4675596 0.79 CYP3A4 (0.40) CYP3A4TNKSPARP1PARP2
SCHEMBL4676160 0.78 HSD11B1 (0.45) ALDH1A1CHRM4MEN1KMT2AMAPK1
SCHEMBL4674536 0.76 PTGDR2 (0.35) —
SCHEMBL4674483 0.75 ALDH1A1 (0.45) ALDH1A1USP2CHRM4KDM4EMAPT
SCHEMBL1833748 0.75 OPRM1 (0.42) ALDH1A1CHRM4KDM4ECYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1997805-A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans Commissariat à l'Energie Atomique (FR) 2008-12-03 — — EP disclosed
Send feedback